Aberrant expression of acute‐phase reactant proteins in sera and breast lesions of patients with malignant and benign breast tumors
Authors:
- Rohana YusofRYRohana Yusof
- Cheng‐Har YipCYCheng‐Har Yip
- Lai‐Meng LooiLLLai‐Meng Looi
- Onn H. HashimOHOnn H. Hashim
- 14 July 2004
- journal article
- research article
- Published by Wiley in Electrophoresis
- Vol. 25 (14) , 2392-2401
Abstract
We have analyzed unfractionated sera of newly diagnosed patients (n = 10) with breast carcinoma (BC), prior to treatment, and patients (n = 5) with fibrocystic disease of the breast (FDB) by two‐dimensional gel electrophoresis (2‐DE) and silver staining. The patients' 2‐DE serum protein profiles obtained were then subjected to image analysis and compared to similar data generated from sera of normal healthy female controls (n = 10) of the same range of age. The relative expression of α1‐antichymotrypsin (ACT), clusterin, and complement factor B was significantly higher in all BC patients as compared to normal controls. However, the expression of α1‐antitrypsin (AAT) in BC patients was apparently lower than that of the controls. Similar differential expression of ACT was detected in the FDB patients. The aberrant expression of the serum acute‐phase proteins of patients with BC and FDB was confirmed by competitive enzyme‐linked immunosorbent assay (ELISA). Similar altered proteins expression was also observed from immunohistochemical studies of malignant (n = 5) and benign (n = 5) breast lesions of the respective patients performed using antisera to the aberrantly expressed proteins. However, the malignant breast lesions were instead positively stained for AAT. The differential expression of the serum proteins was apparently abrogated when a six‐month follow‐up study was performed on nine of the BC patients subsequent to treatment.Keywords
This publication has 15 references indexed in Scilit:
- The Human Plasma ProteomeMolecular & Cellular Proteomics, 2002
- Overexpression of Clusterin in Human Breast CarcinomaThe American Journal of Pathology, 2000
- Acute-Phase Proteins and Other Systemic Responses to InflammationNew England Journal of Medicine, 1999
- 1-Antitrypsin Blocks the Release of Transforming Growth Factor- from MCF-7 Human Breast Cancer CellsThe Journal of Clinical Endocrinology & Metabolism, 1997
- Human serum amyloid A (SAA) protein: a prominent acute‐phase reactant for clinical practiceEuropean Journal of Clinical Investigation, 1996
- Utility of plasmatic levels of alpha-1-antiprotease (A1AP) as a cancer markerCancer Letters, 1995
- Inside SWISS‐2DPAGE databaseElectrophoresis, 1995
- alpha 1-Antitrypsin- and anchorage-independent growth of MCF-7 breast cancer cellsEndocrinology, 1993
- Improved silver staining procedure for fast staining in PhastSystem Development Unit. I. Staining of sodium dodecyl sulfate gelsElectrophoresis, 1988
- The synthesis of a proteinase inhibitor, α‐1‐antichymotrypsin, by human breast epithelial cellsJournal of Supramolecular Structure and Cellular Biochemistry, 1981